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The immune response to Helicobacter pylori involves a mixed T helper-1, T helper-2, and
T helper-17 response. It has been suggested that T helper cells contribute to the gastric
inﬂammatory response during infection, and that T helper 1 (Th1) and T helper 17 (Th17)
subsets may be required for control of H. pylori colonization in the stomach. The relative
contributions of these subsets to gastritis and control of infection are still under investiga-
tion. IL-23 plays a role in stabilizing and expandingTh17 cell cytokine expression. Expression
of IL-23, which is induced in dendritic cells and macrophages following co-culture with H.
pylori, has also been reported to increase during H. pylori infection in humans and ani-
mal models. To investigate the role of IL-23 in H. pylori, we infected IL-23p19 deﬁcient
mice (IL-23−/−) and wild-type littermates with H. pylori strain SS1. At various time points
post-infection, we assessed colonization, gastric inﬂammation, and cytokine proﬁles in the
gastric tissue. Speciﬁcally, H. pylori -infected IL-23−/− mice have higher levels of H. pylori
in their stomachs, signiﬁcantly less chronic gastritis, and reduced expression of IL-17 and
IFNγ compared to H. pylori -infected wild-type mice.While many of these differences were
signiﬁcant, the H. pylori infected IL-23−/− had mild increases in our measurements of dis-
ease severity. Our results indicate that IL-23 plays a role in the activation of the immune
response and induction of gastritis in response to H. pylori by contributing to the control
of infection and severity of gastritis.
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INTRODUCTION
The hallmark of Helicobacter pylori infection is the development
of gastric inﬂammation, referred to as gastritis. It is believed that
all H. pylori infected individuals develop gastritis. In animal mod-
els of disease, the development of gastritis is dependent on the
presence of T lymphocytes (T cells). Severe combined immunod-
eﬁciency mice, which lack B and T cells, require adoptive transfer
of T cells to develop gastritis (Eaton et al., 1999, 2001).
T cells play a decisive role in initiating and shaping pathological
responses in many tissues. Classical examples of T-cell mediated
diseases are inﬂammatory bowel disease (IBD), diabetes, psoriasis,
rheumatoid arthritis, and multiple sclerosis. Interplay, between
T cells and other immune and non-immune cells, is critical in
driving pathologic processes, and T cell-derived cytokines are
essential mediators of this cross-talk. CD4+T cells were tradition-
ally categorized as Th1 or Th2, but over the last decade, research
has characterized a number of new distinct CD4+ T cell subsets
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including Th17 cells, T regulatory cells, T follicular helper cells
(Tfh), and T helper-9 cells. A fundamental function of T helper
cells is to provide “help” to B cells and regulate their proliferation
and immunoglobulin class switching. But CD4+ cells do more
than just help B cells; their cytokine production also regulates
antimicrobial/antiviral responses. For example, IFNγ activates
macrophages and stimulates CD8+ cytotoxic responses, while
IL-17 induces neutrophil migration for clearance of extracellular
pathogens, such asH.pylori. TGF-β,which canbeproducedbynat-
ural Tregs, also controls inﬂammation by inducing Foxp3 expres-
sion in T helper cells stimulating the production of inducible Tregs.
The development of the Th17 lineage may be important for
the control of H. pylori infection and the development of gastritis
during H. pylori infection. Induction of Th17 cells is attributed
to several H. pylori factors including Urease B (Zhang et al.,
2011). Several studies have indicated that H. pylori stimulated
macrophages produce IL-6, TGF-β, IL-23, and CCL20 (Meyer
et al., 2000; Mandell et al., 2004; Odenbreit et al., 2006; Zhuang
et al., 2011).
The gastritis associated with H. pylori infection involves both
acute and chronic inﬂammation suggesting that T cell derived
cytokines such as those produced by Th17 cells may be responsi-
ble for the ongoing acute inﬂammatory response associated with
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the recruitment of neutrophils to the stomach. Th17 lineage devel-
ops in a pathway independent from Th1 and Th2 differentiation
(Bettelli et al., 2008). A hallmark of Th17 cells is the production
of IL-17, IL-21, and IL-22, which are pro-inﬂammatory cytokines.
Th17 cells are known to have an important role in a growing
list of immune-mediated diseases, including IBD, experimental
autoimmune encephalopathy (EAE), and collagen-induced arthri-
tis (CIA; reviewed in McKenzie et al., 2006; Furuzawa-Carballeda
et al., 2007; Sarkar et al., 2007). In addition, in several animal
models of infectious diseases, the IL-23/IL-17 axis promotes cell
migration to the site of infection to kill microorganisms and
activates the bactericidal activity of macrophages (reviewed in
Curtis and Way, 2009). The host’s ability to control the prolifera-
tion of Klebsiella pneumoniae, Citrobacter rodentium, Mycoplasma
pneumoniae,Bordetella pertussis,Pseudomonas aeruginosa,Porphy-
romonas gingivalis, Escherichia coli, Listeria monocytogenes, and
Salmonella enterica is at least partially dependent on IL-23 and
IL-17 (Ye et al., 2001; Mangan et al., 2006; Chen et al., 2007a;
Dubin and Kolls, 2007; Shibata et al., 2007; Wu et al., 2007; Yu
et al., 2007; Hamada et al., 2008; Schulz et al., 2008a). Several
studies from infection models in IL-23p19 deﬁcient mice demon-
strate IL-23 contributes to deﬁcient neutrophil recruitment (Cruz
et al., 2006; Meeks et al., 2009), reduction in IL-17 (Happel et al.,
2005; Khader et al., 2005; Chackerian et al., 2006; Kleinschek et al.,
2006; Schulz et al., 2008b), increase in both disease susceptibility
and organism burden in some infectious models (Happel et al.,
2005; Khader et al., 2005; Meeks et al., 2009), whereas other ani-
mal models exhibit no differences in neither disease susceptibility
nor organism burden (Khader et al., 2005; Chackerian et al., 2006;
Schulz et al., 2008b). IL-17 activates gastric epithelial cells to pro-
duce neutrophil attracting chemokines (Algood et al., 2009). In
some studies, IL-17 is required for control of bacterial load, while
in other studies it is only required for recruitment of neutrophils
(Shiomi et al., 2008; Algood et al., 2009; DeLyria et al., 2009; Otani
et al., 2009).
The development of a Th17 response is promoted by TGF-β,
IL-1β, and IL-6 and further expanded and activated by IL-23. IL-
23 is a heterodimer comprised of an IL-23p19 subunit and an
IL-12p40 subunit. It is produced by a number of immune cells
including macrophages, dendritic cells, and neutrophils. Broadly
speaking, the function of IL-23 resembles the function of IL-12
in linking innate responses and adaptive immunity. IL-23 regu-
lates the secretion of IL-17 through at STAT3 dependent pathway
(Caruso et al., 2008). IL-23 induced activation of STAT3 leads to
direct binding of phosphorylated STAT3 to IL-17A and IL-17F
promoters (Chen et al., 2006). Moreover, STAT3 up-regulates the
expression of Retinoic Acid Receptor-Related Orphan Receptor
Gamma-T (ROR-γ), a Th17 speciﬁc transcriptional regulator that
is critical for the expression of twomembers of IL-17A and IL-17F
(Chen et al., 2007b; Laurence and O’Shea, 2007; Yang et al., 2007).
Although IL-23 is a marker of H. pylori infection (Caruso et al.,
2008), levels of IL-23 alone do not correlate with chronic gastritis,
duodenal, or gastric ulcers (Koussoulas et al., 2009). However, pos-
itive correlationswere foundbetween levels of IL-23 and thedegree
of inﬁltration of neutrophils and monocytes in patients with H.
pylori infection, and the kinetics of IL-23 expression correlates
with those of IL-1β (Koussoulas et al., 2009).
In the current study, we investigated the role of IL-23p19 on
the development of the Th17 and Th1 adaptive immune responses
during H. pylori infection in a mouse model of infection. More-
over, this study investigates the requirement of IL-23p19 in the
development of an effective immune response (control of H. pylori
colonization) and the development of gastritis. Our results indi-
cate that IL-23 contributes to the control of H. pylori infection and
severity of gastritis, playing a role in the activation of the immune
response and induction of gastritis in response to H. pylori.
MATERIALS AND METHODS
ANIMALS
Male and female IL-23+/− mice, on a mixed background (Strain
name B6; 129S5-Il-23atm1Lex/Mmcd) were obtained from theNIH
Consortium (Stock number 011725-UCD MMRC, UC Davis)
for the establishment of a breeding colony. The targeted mouse
gene is IL-23a (interleukin 23, alpha subunit p19), an ortholog of
human IL-23A. Other aliases of IL-23 include P19, SGRF, IL-23,
IL-23A, IL-23P19, interleukin 23p19 subunit, and JKA3 induced
upon T-cell activation. Coding exon 1 was targeted by homolo-
gous recombination. The IL23+/− breeding pairs tested negative
for intestinalHelicobacter.Helicobacter-freemalemice,8–10weeks
old, were used in all experiments. The Vanderbilt University Insti-
tutional Animal Care and Use Committee approved all animal
protocols used in this study. Feces from sentinelmice housed in the
same roomwere routinely testedbyPCR for intestinalHelicobacter,
pinworms,mouseparvovirus,and several othermurinepathogens,
and consistently tested negative for each of these infections.
CULTURE OF H. PYLORI
Amouse-passaged derivative of H. pylori strain SS1 was used in all
animal experiments. For cell culture experiments several strains
were used, including PM-SS1, SS1, 60190, X47, 26695, and 7.13.
Bacteria were grown on trypticase soy agar (TSA) plates contain-
ing 5% sheep blood. Alternatively, bacteria were grown in Brucella
broth containing 10% heat-inactivated fetal bovine serum (FBS)
and 10μg/ml vancomycin. Cultures were grown at 37˚C in either
room air supplementedwith 5%CO2, or undermicroaerobic con-
ditions generated by a CampyPak Plus∗ Hydrogen+CO2 with
Integral Palladium Catalyst (BD).
BONE MARROW PREPARATION
After CO2 euthanasia and cervical dislocation, femurs, and tib-
iae from male mice strains were separated from muscle tissue.
Cleaned bones were collected in 50ml conical tubes on ice with
ice-cold PBS without calcium and magnesium (Cellgro by Medi-
atech, Manassas, VA, USA). Bones were washed by inverting the
tube several times with 1X PBS and then followed by a wash
with ice-cold RPMI 1640 media (Mediatech). Bone marrow was
ﬂushed from the bones with a 21G needle with ice-cold RPMI
1640. Aggregates within the bone marrow suspension were dis-
rupted by pipetting until single cell suspensions were obtained.
Single cell bone marrow suspension was passed through a sterile
70μm nylon cell strainer (Fisherbrand, Pittsburgh, PA, USA) to
remove remaining cellular debris. Bonemarrow cells were pelleted
by centrifugation, red blood cells were removed using water lysis,
and bone marrow cells were then diluted 5× with ice-cold RPMI
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1640, passed through a nylon strainer and then centrifuged.Viable
bone marrow cells were enumerated and were adjusted to a con-
centration of 1× 106 cells/ml in complete RPMI 1640 medium
supplemented with 5% heat-inactivated FBS (Atlanta Biologi-
cals, Miami, FL, USA), 55μM 2-mercaptoethanol, 1mM sodium
pyruvate (GIBCO), and 20 ng/mlmouse granulocyte-macrophage
colony stimulating factor (GM-CSF) premium grade (Miltenyi
Biotec, Boston, MA, USA). Cells were cultured in T75 tissue cul-
ture ﬂasks at 37˚C with 5% atmospheric CO2. After 3 days of
culture,10ml of fresh completemediumcontainingGM-CSFwere
added to the ﬂasks. On day 6 of culture, cells were resuspended by
repeated pipetting and after washing, viable cells were enumerated
as previously described.
POSITIVE SELECTION OF CD11c BONE MARROW-DERIVED DENDRITIC
CELLS BY autoMACS
Bone marrow cells were magnetically labeled with CD11c
Microbeads (Miltenyi Biotec). CD11c+ bone marrow derived
dendritic cells (BMDCs) were positively selected using the positive
selection sensitive program on the autoMACS machine (Miltenyi
Biotec) according to manufacturer’s protocol.
BONE MARROW-DERIVED DENDRITIC CELL CO-CULTURE WITH
H. PYLORI STRAINS
Bone marrow derived dendritic cells were centrifuged at 200× g
for 10min at 4˚C, enumerated, and adjusted to a concentration of
2× 106 cells/ml in RPMI 1640media supplementedwith 5%heat-
inactivated FBS, 55μM 2-mercaptoethanol, and 1mM sodium
pyruvate. One milliliter, 2× 106 cells, were transferred into each
well of a 24 well plate and incubated 1 h at 37˚C with 5% atmos-
pheric CO2 prior to infection with H. pylori strains. BMDCs were
infected at a MOI of ∼50 with given H. pylori strains in dupli-
cate or triplicate wells as indicated. To facilitate contact between
BMDCs and H. pylori, the 24 well plate was centrifuged at 200× g
for 10min at 4˚C. InfectedBMDCswere incubated at 37˚Cwith 5%
atmospheric CO2 for 6 h. After 6 h of culture cells were collected,
resuspended in TRIZOL and RNAwas isolated as described below
for real-time rtPCR analysis. Alternatively, supernatants were col-
lected from these cultures at 24 h. The supernatant medium was
centrifuged and ﬁltered. Supernatants were analyzed for expres-
sion of IL-23p19, IL-1β, IL-6, by using the Searchlight System
(Aushon, Billerica, MA, USA).
INFECTION OF MICE WITH H. PYLORI
One day prior to infection of mice, H. pylori from plate cultures
were inoculated into liquid medium and were cultured for 18 h
under microaerobic conditions, as described above. Mice were
orogastrically inoculated with a suspension of 5× 108 CFU of H.
pylori in 0.5ml of Brucella broth. Mice were inoculated twice over
5 days.
PROCESSING OF MOUSE STOMACHS
The stomach was removed from each mouse by excising between
the esophagus and the duodenum. The forestomach (non-
glandular portion) was removed from the glandular stomach and
discarded. The glandular stomach was opened, rinsed gently in
cold PBS, and cut into three longitudinal strips that were used
for bacterial culture, RNA analysis, and histology. For culturing
of H. pylori from the stomach, gastric tissue was placed into Bru-
cella broth-10% FBS for immediate processing. Gastric tissue was
stored in RNALater (Ambion) solution for subsequent RNA isola-
tion.A longitudinal strip from the greater curvature of the stomach
was excised and placed in 10% normal buffered formalin for 24 h,
embedded inparafﬁn andprocessed routinely for hematoxylin and
eosin (H&E) staining. Indices of inﬂammation and injury were
scored by a single pathologist (KW) who was blinded to the iden-
tity of the mice. Acute and chronic inﬂammation in the gastric
antrum and corpus were graded on a 0-3 scale. Acute inﬂam-
mation was graded based on density of neutrophils and chronic
inﬂammation was graded based on the density of lamina propria
mononuclear cell inﬁltration independent of lymphoid follicles.
The total inﬂammation score is the sum of the chronic and acute
inﬂammation scores in the antrum and the corpus.
CULTURE OF H. PYLORI FROM MOUSE STOMACH
Gastric tissue was homogenized using the Tissue Tearor (BioSpec
Products, Bartlesville, OK, USA). Serial dilutions of the homo-
genate were plated on trypticase soy agar, containing 5% sheep
blood, 10μg/ml nalidixic acid, 100μg/ml vancomycin, 2μg/ml
amphotericin, and 200μg/ml bacitracin (all antibiotics were pur-
chased from Sigma). After 5–7 days of culture under microaerobic
conditions, H. pylori colonies were counted and the number of
colony forming units per gram of tissue calculated (CFU/g).
RNA EXTRACTION AND REAL-TIME rtPCR
RNA was isolated from the stomach using the TRIZOL isolation
protocol (Invitrogen, Carlsbad, CA, USA) with slight modiﬁca-
tions. Stomach tissuewas homogenized in 1ml of TRIZOL reagent
and then two chloroform extractions were performed. Follow-
ing an isopropanol precipitation, the RNA was washed with 70%
ethanol and treated with RNase Inhibitor (Applied Biosystems,
Foster City, CA, USA) for 30min. The RNA was resuspended at
65˚C for 15min and RNApreparations were further puriﬁed using
the Qiagen RNA isolation kit as directed by the manufacturer
(Qiagen Inc., Valencia, CA, USA). RNA was reverse transcribed
using theHigh Capacity cDNAReverse Transcription Kit (Applied
Biosystems, Foster City, CA, USA). For real time rtPCR, we used
the relative gene expression method (Giulietti et al., 2001). Glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH) served as the
normalizer, and tissue from uninfected mouse stomachs served as
the calibrator. All cDNA samples were analyzed in triplicate, along
with “no reverse transcriptase” controls, using an Applied Biosys-
tems StepOne Plus real time PCR instrument. Levels of cytokine
expression are indicated as “normalized expression,” based on
comparison of tissue fromH. pylori-infectedmicewith tissue from
uninfected mice (calibrator tissue; Giulietti et al., 2001). Relative
units (or normalized expression) were calculated as 2∧-ΔΔCt (Ct,
cycle threshold) where ΔΔCt is equal to the difference between
the ΔCt of the gene of interest of the experimental sample and
the ΔCt of the gene of interest of the calibrator tissue. The ΔCt of
the gene of interest is calculated as the difference between the cycle
threshold of the gene of interest and the cycle threshold of GAPDH
(our normalizer). Primer and probe sets were purchased as Taq-
man Gene Expression Assays from Applied Biosystems [IL-1β
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(accession number Mm00434227_g1), IL-6 (Mm99999064_m1),
IL-10 (Mm01288386_m1), IL-12a (Mm00434165_m1), IL-
17a (Mm00439619_m1), IL-23a (Mm01160011_g1), Foxp3
(Mm00475162_m1),GAPDH (Mm99999915_g1), IFNγ (Mm999
99071_m1)].
STATISTICAL ANALYSIS
Four to six mice per group per time point were used for all of
the studies. To compare results obtained with different groups of
mice, statistical analysis was performed using an unpaired stu-
dent’s T test utilizing GraphPad Prism software. For analyses of
bacterial numbers and cell numbers, the data were normalized
by log transformation prior to statistical analysis. For histology
scores, the Mann-Whitney U-test was applied to compare results
between IL23+/+ and IL-23−/− mice.
RESULTS
IL-23p19 AND Th17 INDUCING CYTOKINES ARE STIMULATED IN
DENDRITIC CELLS BY H. PYLORI
The ability of DCs to sense infection and to differentially secrete
both IL-12 and IL-23 are critical to the initiation of both Th1 and
Th17 responses to pathogens. To determine whether Th17 induc-
ing cytokines were upregulated in dendritic cells upon exposure
toH. pylori, BMDCwere generated fromwild-type mice (both IL-
23+/+micewhich are on amixed background, andC57Bl/6mice)
and co-cultured with H. pylori. The results indicate that H. pylori
co-culturewithBMDCs inducesmRNAexpression of Th17 induc-
ing cytokines, IL-1β and IL-6, and IL-23p19 (Figure 1A), which
likely enhances IL-17 expression through a STAT3 dependent
mechanism.The increase in IL-1β and IL-6, and IL-23p19was con-
ﬁrmed using a protein basedmultiplex assay on supernatants from
24 h co-cultures (Figure 1C). Moreover, Th1 inducing cytokine,
IL-12p40, and regulatory cytokine, IL-10, also increase in expres-
sion relative to untreated dendritic cells (Figure 1B). Several
strains were used to investigate whether different virulence factors
would inﬂuence the dendritic cell’s cytokine response. For exam-
ple PM-SS1 and SS1 were compared to investigate the inﬂuence of
a functional type IV secretion system (theCag pathogenicity island
CagPAI). PM-SS1 (pre-mouse SS1) contains a functional CagPAI,
whereas in SS1 the CagPAI is no longer intact. Our data indicate
that the cytokine expression by the dendritic cells is independent
of a functional CagPAI (Figures 1A,B). Several additional strains
of H. pylori (including 26695, 60190, 7.13, and X47) were also
used in this co-culture system and induce these cytokines in den-
dritic cellswithno signiﬁcant differences between thedendritic cell
cytokine responses with these H. pylori strains (data not shown).
FIGURE 1 | Dendritic cell co-cultures with H. pylori.When cultured
with H. pylori strains SS1 or PM-SS1, bone marrow derived dendritic
cells from wild-type mice produce (A). Th17 inﬂuencing cytokines
(IL-1β, IL-6, and IL-23a), (B). Regulatory cytokine IL-10 andTh1 inducing
cytokine IL-12. Real time rtPCR was performed to measure cytokine
expression at 6 h of co-culture with and without H. pylori. Graphs are
representative of four independent experiments. (C)Th17 inﬂuencing
cytokines (IL-1β, IL-6, and IL-23a) protein levels in the supernatants from
dendritic cell- H. pylori co-cultures at 24 h (units for each cytokine are
noted on the x -axis).
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Performing similar experiment to compare cytokine expression
at 6 h of co-culture in IL-23+/+ verse IL-23−/− BMDC, we
observed no consistent statistical differences in the expression of
these cytokines (datanot shown)with the exceptionof IL-23which
as expected was not detected in the IL-23−/− BMDC.
IL-23p19 DEFICIENT MICE CARRY HIGHER H. PYLORI BACTERIAL LOADS
DURING CHRONIC INFECTION
To investigate whether a deﬁciency in IL-23p19 leads to a change in
the ability of themice to controlH. pylori colonization,we infected
IL-23−/− mice and IL-23+/+ mice with H. pylori strain SS1 and
followed the course of infection for up to 4months. At 1month
post-infection, there was no signiﬁcant difference in the bacter-
ial burden in the IL-23−/− mice compared to the IL-23+/+ mice
(data not shown). By 3 and 4months post infection, the IL-23−/−
mice did not control the bacterial burden as well as the IL-23+/+
mice (Figure 2).
IL-23p19 IS REQUIRED FOR HIGH LEVELS OF T HELPER CYTOKINE
EXPRESSION DURING H. PYLORI INFECTION
To determine whether IL-23p19 deﬁcient mice have reduced
expression of T cell derived cytokines, IL-17, and IFNγ, we per-
formed real time rtPCR on stomach tissue of IL-23−/− and
IL-23+/+ mice during chronic H. pylori infection. Our data
indicate that H. pylori infected IL-23−/− mice have signiﬁcantly
reduced expression of IL-17 and IFNγ by 3months post infection
compared to H. pylori infected IL23+/+ mice (Figure 3).
To investigate whether the decrease in pro-inﬂammatory T cell
cytokines was a result of an increase in Treg cells, we assayed for
expression of Foxp3 in the tissue. We were unable to detect any
signiﬁcant differences in expression of Foxp3 comparing H. pylori
infected IL-23−/− mice and H. pylori infected IL-23+/+ mice at
3 or 4months post infection (data not shown).
IL-23p19-DEFICIENT MICE HAVE MINIMAL CHRONIC GASTRITIS
To investigate the impact of the IL-23 deﬁciency, increased bac-
terial burden and decreased T helper responses in the stomachs
of the IL-23−/− mice on the inﬂammatory response, we scored
the stomach tissue for both chronic and acute inﬂammation
(see methods for how these types of inﬂammation are deﬁned).
Our data indicate that there is no signiﬁcant difference in total
inﬂammation (sum of acute and chronic inﬂammation in the cor-
pus and antrum) between IL-23−/− mice and IL-23+/+ mice
(p = 0.0521;Figure 4A) at 3months post infection.However, there
is a signiﬁcant decrease in the chronic inﬂammatory scores of H.
pylori-infected IL-23−/− mice compared to H. pylori infected
IL-23+/+ littermates at 3months post infection (p = 0.0074;
Figure 4B). At 4months post infection, while there was a trend
toward decreased total inﬂammation in the H. pylori-infected IL-
23−/− mice compared to H. pylori-infected wild-type mice, the
differences were not signiﬁcant (p = 0.20, data not shown).
PEYER’S PATCHES FROM IL-23−/− MICE HAVE DIFFERENTIAL
EXPRESSION OF IL-12p40
In a mouse model of infection it has been demonstrated that
Peyer’s patches are required for the development of gastritis in
the stomach (Nagai et al., 2007). To investigate whether defective
priming accounted for the reduced level of chronic inﬂammation
observed in the IL-23 deﬁcient mice, we measured the expression
of cytokines known to inﬂuence T cell priming (IL-23p19, and
IL-12p40) in the Peyer’s Patches of both H. pylori infected IL-
23−/− and IL-23+/+ mice. Moreover wemeasured expression of
IFNγ, IL-17, and Foxp3 as ameasure of Th responses in the Peyer’s
patches.
While expression of IL-17, IFNγ, and Foxp3 was similar in
H. pylori-infected IL-23−/− and IL23+/+ mice during chronic
infection (Figure 5A), the levels of IL-12p40 were signiﬁcantly
higher (relative to uninfected wild type mice) in IL-23−/− mice
when compared to IL-23+/+ mice (Figure 5B). Analysis of IL-
12p40 gene expression in the stomach and in the spleenwas similar
in H. pylori infected IL-23−/− and H. pylori infected IL-23+/+
mice (Figure 5B). To investigate whether differences in baseline
expression of IL-12p40 mRNA accounted for this difference in
the Peyer’s patches, we measured IL-12p40 mRNA expression in
uninfected IL-23−/− v. uninfected IL-23+/+. The data indicate
that IL-23−/− mice exhibit about twofold higher levels of IL-12
than uninfected IL-23+/+ mice (data not shown).
DISCUSSION
The T helper response, which develops toward H. pylori infection,
is amixed response. The level of gastritis and bacterial colonization
FIGURE 2 | Colonization of IL-23p19 deficient mice with H. pylori.
IL-23−/− mice and IL-23+/+ littermates were infected with H. pylori strain
SS1 for 3 and 4months. Levels of colonization were measured by plating
serial dilutions of stomach homogenates. The number of colony forming units
(CFU) per gram of stomach tissue is presented on the graphs for 3months
post-infection (A) and 4months post-infection (B).
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FIGURE 3 |Th17 andTh1 responses are reduced in H. pylori infected
IL-23−/−mice compared to H. pylori infected IL-23+/+ mice. Real time
rtPCR was performed on stomach tissue of H. pylori infected mice. Relative
units of IFNγ (A) and IL-17A (B) were measured at 3months post-infection.
Graphs are representative of three independent experiments.
may be dependent on the balance between Th1, Th17, and Treg
responses. Because Th1 and Th17 cells likely contribute to pro-
tective immunity to H. pylori, understanding the contributions of
cytokines produced by innate immune responses which inﬂuence
the T helper responses is of great interest to understanding this
balance. Our study speciﬁcally investigated the contribution of
IL-23 on the development of T cell responses and gastritis.
IL-23 drives intestinal pathology in experimental models of T
cell-dependent and innate colitis (Hue et al., 2006; Kullberg et al.,
2006; Uhlig et al., 2006; Yen et al., 2006; Elson et al., 2007); there-
fore we hypothesized that it would also drive H. pylori-induced
pathology in the stomach. Our studies on BMDCs indicate that
culture of dendritic cells with H. pylori (at an MOI of 50) leads to
increased expression of IL-23, IL-1β, IL-6, IL-12, and IL-10 by 6 h
post infection.We have observed the increased expression of these
cytokineswith several strains ofH. pylori suggesting that themajor
determinants of dendritic cell activation are not dependent on the
FIGURE 4 | Inflammation is reduced in H. pylori infected IL-23−/−mice
compared to H. pylori infected IL-23+/+ mice. Levels of acute and
chronic inﬂammation were scored on stomach tissue (in the corpus and
antrum) at 3months post infection. Total inﬂammation (A) was scored on a
scale of 0–12. Chronic inﬂammation (B) in the corpus and antrum was
scored on a scale of 0–6.
CagPAI or VacA since these strains vary in their expression of the
Type IV secretion system and express various isoforms of the vac-
uolating toxin, VacA (if any). These data are consistent with data
published by Kao et al. (2010) which indicated that CagA deletion
did not affect the Treg skewing of H. pylori treated-DCs. Contrary
to our results, Tanaka et al. (2010) present data which suggests the
presence of CagA contributes to regulation of cytokine production
in DCs co-cultured with H. pylori.
In the mouse model of infection, our data suggests that IL-
23 makes a minor contribution to the development of chronic
gastritis in this model of H. pylori infection. For instance, differ-
ences in gastritis were only observed at chronic time points (3 and
4months post infection) and in chronic inﬂammation (when data
is stratiﬁed, no differences were observed in acute inﬂammation).
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FIGURE 5 | Peyer’s patches expressT cell skewing cytokines during
chronic infection. Levels of Foxp3, IFNγ, and IL-17A (A), IL-12p40 (B)
were measured by real time rtPCR at 3 and 4months post infection.
Normalized expression also known as relative units are the relative
expression calibrated to uninfected wild-type with GAPDH as the
endogenous control. Due to differences in IL-12p40 in the Peyer’s
patches, IL-12p40 expression was also measured in the spleen and
gastric mucosa (B).
It is clear that IL-23 plays a role in expanding and maintaining
the Th17 subset of CD4+ T helper cells. In addition, there is evi-
dence in mouse models of M. tuberculosis and H. hepaticus that
IL-23 is involved in inducing IFNγ production by CD4+ T-cell
(Khader et al., 2005; Kullberg et al., 2006). Our studies indicate
that IL-23 makes a contribution to both Th1 and Th17 responses
during H. pylori infection especially during the chronic stage of
infection. By 3months post infection, IL-23−/− mice have signif-
icantly reduced IL-17 and IFNγ expression compared to H. pylori
infected wild-type mice. It is important to recognize that Th17
cells are likely still developing in these IL-23−/− mice, but overall
expression of IL-17a is lower.We were unable to detect differences
in neither IL-21 nor IL-17f in these studies (data not shown). Due
to the increased bacterial burden in the stomachs of IL-23−/−
mice compared to wild-type mice, we speculate that chronic bac-
terial exposure in conjunctionwith ongoing stimulation of antigen
presenting cells and continual expression of IL-1β, IL-6, and TGFβ
would drive Th17 differentiation even in the absence of IL-23
expanding and maintaining the population of cells.
IL-23 has been reported to inhibit the accumulation of Foxp3+
Tregs in the intestines. IL-23 receptor deﬁcient (IL-23R−/−) T
cells adoptively transferred into Rag−/− recipients demonstrate
an increased ability to develop into Tregs compared to wild-type
T cells adoptively transferred into Rag−/− recipients. Moreover,
there is evidence that IL-23may inhibit IL-10production.To inves-
tigate the effects of IL-23 on the development of Tregs in ourmouse
model of H. pylori infection, we measured Foxp3 expression in
both the stomach and the Peyer’s patches. Our data indicate there
is no signiﬁcant difference in expression of Foxp3 comparing H.
pylori infected IL-23−/− and wild-type mice.
Our ﬁndings that the levels of chronic inﬂammation were
signiﬁcantly reduced in theH. pylori infected IL-23−/−mice com-
pared to H. pylori infected wild-type mice has led us to question
how efﬁcient priming is in the IL-23−/−mice. Unfortunately, this
is a very difﬁcult question to answer with few deﬁned antigens for
H. pylori. Based on the evidence that in the absence of Peyer’s
patches there is no gastritis (Nagai et al., 2007), we focused on
this site to investigate the activation of innate T helper driving
cytokines, IL-12 and IL-23, and measured expression of Foxp3 as
a marker for Treg development. Our ﬁndings suggest that in the
absence of IL-23, there may be an increase in the baseline expres-
sion (in uninfected mice) of IL-12, which suggests that there may
be inherited differences in the ability of these mice to develop Th1
responses. We would have expected IL-23−/− mice to have lower
IL-12 in the Peyer’s patches since their Th1 responses are depressed
in the gastric mucosa. Previously, Becker et al. (2006) demon-
strated that IL-23 candownregulateTLR-induced IL-12 expression
suggesting that IL-23 can indirectly inhibit Th1 responses, but our
data suggests that in the absence of IL-23, both Th1 and Th17
responses are depressed in the gastric mucosa. We speculate that
while the Peyer’s patches may be a site for T cell priming a poten-
tial surrogate marker for what is happening in the gastric mucosa,
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primed T cells must still receive the correct signals to migrate into
the gastric mucosa from the Peyer’s patches. Therefore, IL-23 and
the Th17 response may be necessary for inﬂammation to initiate
a cascade of chemokines which would then also recruit Th1 cells
to the site of infection.
The study was performed on mice which were obtained from
the NIH Consortium and they are described as B6:129 mice,
therefore they are on a mixed background. We used wild-type
littermates as controls for the IL-23−/− mice. The B6:129 mice
exhibit amilder gastritis response compared toC57Bl/6mice (total
inﬂammatory scores are often higher in WT C57Bl/6 mice than
these B6:129 WT mice, Algood et al., 2009). We also observed
more variation within groups which may be a result of the mixed
background of the mice. While it may be somewhat cumbersome,
there is a need for a study which would experimentally measure
T cell priming and activation in various secondary lymphatic tis-
sues over time, with multiple strains of H. pylori, in several strains
of inbred mice. It is likely that the differences in inﬂammation
observed in mice of different backgrounds could be correlated
with differences in the magnitude of T cell priming in the lym-
phatics, the ratio of Th1:Th17:Treg development, and the timing
of the response.
In this study in particular, we have demonstrated that IL-
23 plays a minor role in control of H. pylori induced gastritis.
Reduced chronic inﬂammation correlates with reduced Th17 and
Th1 cytokine expression in the stomachs of the H. pylori-infected
IL-23−/− mice compared to wild-type mice. In future studies,
it will be of interest to investigate T cell priming early during
infection and the role IL-23 plays at the sites of priming.
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